Category - Markets

Markets

Paradigm starts Cansortium at buy; PT $2.40 to $3.40

Paradigm launched coverage of Cansortium (CSE:TIUM) with a “buy” rating and a price target between $2.40 and $3.40. The stock closed at $1.59 on May 23.

May 24, 2019

Markets

HCW ups Aurinia price target to $25

H.C. Wainwright raised its price target for Aurinia Pharmaceuticals (NASDAQ:AUPH) to $25 from $15 after assessing the value of the company’s recently-received new dosing regimen patent. The stock closed at $6.49 on May...

May 23, 2019

Markets

HCW starts Aeglea BioTherapeutics at buy; PT $20

H.C. Wainwright launched coverage of Aeglea BioTherapeutics (NASDAQ:AGLE) with a “buy” rating and $20 price target. The stock closed at $6.92 on May 21.

May 22, 2019

Markets

BTIG starts Matinas BioPharma at buy; PT $5

BTIG launched coverage of Matinas BioPharma Holdings (NYSE AMER:MTNB) with a “buy” rating and $5 price target. The stock closed at 94 cents on May 16.

May 17, 2019

Markets

Alliance Global starts T2 Biosystems at buy; PT $5.00

Alliance Global Partners launched coverage of T2 Biosystems (NASDAQ:TTOO) with a “buy” rating and price target of $5.00. The stock closed at $2.62 on May 15.

May 16, 2019

Markets

BTIG cuts electroCore to neutral

BTIG downgraded electroCore (NASDAQ:ECOR) to a “neutral” rating following the company’s release of its first quarter 2019 results. The stock closed at $5.33 on May 14.

May 15, 2019

Markets

BTIG ups TransEnterix to buy; PT $3

BTIG upgraded TransEnterix (NASDAQ:TRXC) to “buy” from “neutral” with a price target of $3, saying it sees more upside potential than downside risk at current share prices.

May 14, 2019

Markets

Roth starts Seelos Therapeutics at buy; PT $8

Roth Capital partners launched coverage of Seelos Therapeutics (NASDAQ:SEEL) with a “buy” rating and $8 price target. The stock closed at $2.71 on May 13.

May 14, 2019

Markets

BTIG starts MannKind at buy; PT $3

BTIG initiated coverage of MannKind (NASDAQ:MNKD) with a “buy” rating and price target of $3. The stock closed at $1.23 on May 13.

May 14, 2019

Markets

Alliance Global starts Canopy Growth at buy; PT $75 (Canadian)

Alliance Global Partners launched coverage of Canopy Growth (TSX:WEED; NYSE:CGC) with a “buy” rating and $75 price target. The stock closed at $63.78 on May 10.

May 13, 2019

Category - Markets

Paradigm starts Cansortium at buy; PT $2.40 to $3.40

HCW ups Aurinia price target to $25

HCW starts Aeglea BioTherapeutics at buy; PT $20

BTIG starts Matinas BioPharma at buy; PT $5

Alliance Global starts T2 Biosystems at buy; PT $5.00

BTIG cuts electroCore to neutral

BTIG ups TransEnterix to buy; PT $3

Roth starts Seelos Therapeutics at buy; PT $8

BTIG starts MannKind at buy; PT $3

Alliance Global starts Canopy Growth at buy; PT $75 (Canadian)

General

More